Clinical Trial Update: Pediatric GVHD Low Risk Steroid Taper Trial [Phase 2]

View source ↗

Summary

Phase 2 pediatric trial evaluating a low-risk steroid taper strategy for acute graft-versus-host disease in allogeneic bone marrow transplant recipients; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: John Levine | Conditions: Acute Graft vs Host Disease, Allogeneic Bone Marrow Transplantation | Phase 2 | Status: ACTIVE_NOT_RECRUITING